Page last updated: 2024-10-18

glycine and Precancerous Conditions

glycine has been researched along with Precancerous Conditions in 5 studies

Precancerous Conditions: Pathological conditions that tend eventually to become malignant.

Research Excerpts

ExcerptRelevanceReference
" Here, we demonstrate in an in vivo transgenic model in which atorvastatin reverses and prevents the onset of MYC-induced lymphomagenesis, but fails to reverse or prevent tumorigenesis in the presence of constitutively activated K-Ras (G12D)."7.74Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. ( Chang, M; Chen, J; Elchuri, S; Fan, AC; Felsher, DW; Goldstein, MJ; Mitchell, DJ; Nolan, GP; Perez, OD; Shachaf, CM; Sharpe, O; Shirer, AE; Steinman, L; Youssef, S, 2007)
" Here, we demonstrate in an in vivo transgenic model in which atorvastatin reverses and prevents the onset of MYC-induced lymphomagenesis, but fails to reverse or prevent tumorigenesis in the presence of constitutively activated K-Ras (G12D)."3.74Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis. ( Chang, M; Chen, J; Elchuri, S; Fan, AC; Felsher, DW; Goldstein, MJ; Mitchell, DJ; Nolan, GP; Perez, OD; Shachaf, CM; Sharpe, O; Shirer, AE; Steinman, L; Youssef, S, 2007)

Research

Studies (5)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's5 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Houli, N1
Loh, SW1
Giraud, AS1
Baldwin, GS2
Shulkes, A2
Shachaf, CM1
Perez, OD1
Youssef, S1
Fan, AC1
Elchuri, S1
Goldstein, MJ1
Shirer, AE1
Sharpe, O1
Chen, J1
Mitchell, DJ1
Chang, M1
Nolan, GP1
Steinman, L1
Felsher, DW1
Bunaciu, RP1
Tharappel, JC1
Lehmler, HJ1
Kania-Korwel, I1
Robertson, LW1
Srinivasan, C1
Spear, BT1
Glauert, HP1
Ralhan, R1
Agarwal, S1
Mathur, M1
Wasylyk, B1
Srivastava, A1
Aly, A1

Other Studies

5 other studies available for glycine and Precancerous Conditions

ArticleYear
Mitogenic effects of both amidated and glycine-extended gastrin-releasing peptide in defunctioned and azoxymethane-treated rat colon in vivo.
    Regulatory peptides, 2006, Mar-15, Volume: 134, Issue:1

    Topics: Animals; Azoxymethane; Cell Proliferation; Colon; Colonic Neoplasms; Gastrin-Releasing Peptide; Glyc

2006
Inhibition of HMGcoA reductase by atorvastatin prevents and reverses MYC-induced lymphomagenesis.
    Blood, 2007, Oct-01, Volume: 110, Issue:7

    Topics: Animals; Atorvastatin; Cell Survival; Cell Transformation, Neoplastic; Cells, Cultured; Flow Cytomet

2007
The effect of dietary glycine on the hepatic tumor promoting activity of polychlorinated biphenyls (PCBs) in rats.
    Toxicology, 2007, Oct-08, Volume: 239, Issue:3

    Topics: Administration, Oral; Alkylating Agents; Animals; Body Weight; Carcinogens, Environmental; Cell Prol

2007
Association between polymorphism in p21(Waf1/Cip1) cyclin-dependent kinase inhibitor gene and human oral cancer.
    Clinical cancer research : an official journal of the American Association for Cancer Research, 2000, Volume: 6, Issue:6

    Topics: Adult; Aged; Alleles; Antibodies, Monoclonal; Apoptosis; Aspartic Acid; Carcinoma, Squamous Cell; Ce

2000
Short term infusion of glycine-extended gastrin(17) stimulates both proliferation and formation of aberrant crypt foci in rat colonic mucosa.
    International journal of cancer, 2001, Nov-01, Volume: 94, Issue:3

    Topics: Animals; Azoxymethane; Carcinogens; Cell Division; Colon; Colonic Neoplasms; Gastrins; Glycine; Horm

2001